APONTIS PHARM. AG INH ON/ DE000A3CMGM5 /
| 2024-11-15 5:36:22 PM | Chg. +0.060 | Volume | Bid2024-11-15 | Ask2024-11-15 | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 9.760EUR | +0.62% | 29,906 Turnover: 290,521.560 |
-Bid Size: - | -Ask Size: - | 81.94 mill.EUR | 0.00% | - |
Assets
|
2021 HGB in mill. EUR |
||
|---|---|---|---|
| Property and Equipment | .0200 | ||
| Intangible Assets | 14.7000 | ||
| Long-Term Investments | .8000 | ||
| Fixed Assets | - | ||
| Inventories | 4.6000 | ||
| Accounts Receivable | 2.9000 | ||
| Cash and Cash Equivalents | 29.8000 | ||
| Current Assets | 38 | ||
| Total Assets | 54.1000 | ||
Liabilities
|
2021 HGB in mill. EUR |
||
|---|---|---|---|
| Accounts Payable | - | ||
| Long-term debt | - | ||
| Liabilities to Banks | - | ||
| Provisions | - | ||
| Liabilities | 12.7000 | ||
| Share Capital | 8.5000 | ||
| Total Equity | 40.7000 | ||
| Minority Interests | - | ||
| Total liabilities equity | 54.1000 | ||
Income Statement
|
2021 HGB in mill. EUR |
||
|---|---|---|---|
| Revenues | 51.2000 | ||
| Depreciation (total) | 1.7000 | ||
| Operating Result | 10.4000 | ||
| Interest Income | -.4000 | ||
| Income Before Taxes | 1.3000 | ||
| Income Taxes | .7000 | ||
| Minority Interests Profit | - | ||
| Net Income | 1 | ||
Per Share
Cash Flow
|
2021 HGB in mill. EUR |
||
|---|---|---|---|
| Cash Flow from Operating Activities | 3.4000 | ||
| Cash Flow from Investing Activities | -1.8000 | ||
| Cash Flow from Financing | 20.1000 | ||
| Decrease / Increase in Cash | 21.8000 | ||
| Employees | 176 | ||
